Mind the Brain
This exhibition marks the 10th anniversary of the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, which represents an important milestone for biomedical research in Luxembourg.
Combining art with science, Mind the Brain exhibits 10 giant sculptures in the shape of a brain throughout the city center of Luxembourg. Each of the giant brains has been painted by a renowned Luxembourgish artist and represents one of the research areas of the LCSB. The exhibition offers a gateway to biomedical science for the public, with accessible information on research conducted at the LCSB.
Fundraising for art and science
To support both Luxembourgish art and biomedical research, the 10 sculptures are on sale. Half of the funds collected will go to the artists and the other half will support a research project in the field of neurodegenerative diseases.
A social media campaign in partnership with Hogan Lovells Luxembourg will also help raise funds: for each photo of a brain sculpture posted with the hashtag #MindtheBrain, the law firm will give 1€ to biomedical research!
About the Luxembourg Centre for Systems Biomedicine (LCSB)
The LCSB is an interdisciplinary research centre at the University of Luxembourg. It is accelerating biomedical research by closing the link between systems biology and medical research. Collaboration between biologists, medical and computer scientists, physicists, engineers as well as mathematicians is offering new insights in complex systems like cells, organs and organisms. These findings are essential for understanding principal mechanisms of disease pathogenesis and for developing new tools in diagnostics and therapy. Neurodegenerative diseases like Parkinson’s Disease and description of diseases as networks are the main focus of LCSB’s research. The Centre has established strategic partnerships with leading biomedical laboratories worldwide and with all major biological and medical research units in Luxembourg. The LCSB fosters collaboration with industrial partners and has founded several spin-off companies, thereby accelerating the translation of fundamental research results into clinical applications.